Copyright Reports & Markets. All rights reserved.

Global Antimalarial Drug Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Antimalarial Drug Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Plasmodium Falciparum
      • 1.4.3 Plasmodium Vivax
      • 1.4.4 Plasmodium Malariae
      • 1.4.5 Plasmodium Ovale
    • 1.5 Market by Application
      • 1.5.1 Global Antimalarial Drug Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacy
      • 1.5.3 Retail Pharmacy
      • 1.5.4 E-Commerce
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Antimalarial Drug Market Size
    • 2.2 Antimalarial Drug Growth Trends by Regions
      • 2.2.1 Antimalarial Drug Market Size by Regions (2014-2025)
      • 2.2.2 Antimalarial Drug Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Antimalarial Drug Market Size by Manufacturers
      • 3.1.1 Global Antimalarial Drug Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Antimalarial Drug Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Antimalarial Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Antimalarial Drug Key Players Head office and Area Served
    • 3.3 Key Players Antimalarial Drug Product/Solution/Service
    • 3.4 Date of Enter into Antimalarial Drug Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Antimalarial Drug Market Size by Type (2014-2019)
    • 4.2 Global Antimalarial Drug Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Antimalarial Drug Market Size (2014-2019)
    • 5.2 Antimalarial Drug Key Players in United States
    • 5.3 United States Antimalarial Drug Market Size by Type
    • 5.4 United States Antimalarial Drug Market Size by Application

    6 Europe

    • 6.1 Europe Antimalarial Drug Market Size (2014-2019)
    • 6.2 Antimalarial Drug Key Players in Europe
    • 6.3 Europe Antimalarial Drug Market Size by Type
    • 6.4 Europe Antimalarial Drug Market Size by Application

    7 China

    • 7.1 China Antimalarial Drug Market Size (2014-2019)
    • 7.2 Antimalarial Drug Key Players in China
    • 7.3 China Antimalarial Drug Market Size by Type
    • 7.4 China Antimalarial Drug Market Size by Application

    8 Japan

    • 8.1 Japan Antimalarial Drug Market Size (2014-2019)
    • 8.2 Antimalarial Drug Key Players in Japan
    • 8.3 Japan Antimalarial Drug Market Size by Type
    • 8.4 Japan Antimalarial Drug Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Antimalarial Drug Market Size (2014-2019)
    • 9.2 Antimalarial Drug Key Players in Southeast Asia
    • 9.3 Southeast Asia Antimalarial Drug Market Size by Type
    • 9.4 Southeast Asia Antimalarial Drug Market Size by Application

    10 India

    • 10.1 India Antimalarial Drug Market Size (2014-2019)
    • 10.2 Antimalarial Drug Key Players in India
    • 10.3 India Antimalarial Drug Market Size by Type
    • 10.4 India Antimalarial Drug Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Antimalarial Drug Market Size (2014-2019)
    • 11.2 Antimalarial Drug Key Players in Central & South America
    • 11.3 Central & South America Antimalarial Drug Market Size by Type
    • 11.4 Central & South America Antimalarial Drug Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Antimalarial Drug Introduction
      • 12.1.4 Pfizer Revenue in Antimalarial Drug Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 GlaxoSmithKline
      • 12.2.1 GlaxoSmithKline Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Antimalarial Drug Introduction
      • 12.2.4 GlaxoSmithKline Revenue in Antimalarial Drug Business (2014-2019)
      • 12.2.5 GlaxoSmithKline Recent Development
    • 12.3 Ranbaxy Laboratories
      • 12.3.1 Ranbaxy Laboratories Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Antimalarial Drug Introduction
      • 12.3.4 Ranbaxy Laboratories Revenue in Antimalarial Drug Business (2014-2019)
      • 12.3.5 Ranbaxy Laboratories Recent Development
    • 12.4 Ipca Laboratories Ltd
      • 12.4.1 Ipca Laboratories Ltd Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Antimalarial Drug Introduction
      • 12.4.4 Ipca Laboratories Ltd Revenue in Antimalarial Drug Business (2014-2019)
      • 12.4.5 Ipca Laboratories Ltd Recent Development
    • 12.5 Zydus Cadila
      • 12.5.1 Zydus Cadila Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Antimalarial Drug Introduction
      • 12.5.4 Zydus Cadila Revenue in Antimalarial Drug Business (2014-2019)
      • 12.5.5 Zydus Cadila Recent Development
    • 12.6 Merck KGaA
      • 12.6.1 Merck KGaA Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Antimalarial Drug Introduction
      • 12.6.4 Merck KGaA Revenue in Antimalarial Drug Business (2014-2019)
      • 12.6.5 Merck KGaA Recent Development
    • 12.7 Novartis AG
      • 12.7.1 Novartis AG Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Antimalarial Drug Introduction
      • 12.7.4 Novartis AG Revenue in Antimalarial Drug Business (2014-2019)
      • 12.7.5 Novartis AG Recent Development
    • 12.8 Alvizia Health Care
      • 12.8.1 Alvizia Health Care Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Antimalarial Drug Introduction
      • 12.8.4 Alvizia Health Care Revenue in Antimalarial Drug Business (2014-2019)
      • 12.8.5 Alvizia Health Care Recent Development
    • 12.9 Bayer
      • 12.9.1 Bayer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Antimalarial Drug Introduction
      • 12.9.4 Bayer Revenue in Antimalarial Drug Business (2014-2019)
      • 12.9.5 Bayer Recent Development
    • 12.10 Roche
      • 12.10.1 Roche Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Antimalarial Drug Introduction
      • 12.10.4 Roche Revenue in Antimalarial Drug Business (2014-2019)
      • 12.10.5 Roche Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Antimalarial Drug market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Antimalarial Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antimalarial Drug development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      GlaxoSmithKline
      Ranbaxy Laboratories
      Ipca Laboratories Ltd
      Zydus Cadila
      Merck KGaA
      Novartis AG
      Alvizia Health Care
      Bayer
      Roche

      Market segment by Type, the product can be split into
      Plasmodium Falciparum
      Plasmodium Vivax
      Plasmodium Malariae
      Plasmodium Ovale

      Market segment by Application, split into
      Hospital Pharmacy
      Retail Pharmacy
      E-Commerce
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Antimalarial Drug status, future forecast, growth opportunity, key market and key players.
      To present the Antimalarial Drug development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Antimalarial Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now